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Object: By making the “vascularized nerve ﬂap for complete spinal cord gap” model,
we assessed the histological effect of this method. Method: Eight female Sprague-
Dawley rats were divided into 2 groups: group A and group B. Group A included
“nonvascularized nerve ﬂap” models, whereas group B consisted of “vascularized nerve
ﬂap” models. In each group, we transferred peripheral nerves to ﬁll the void made by
complete surgical transection of the spinal cord. Postoperatively, we administered in-
travenous antibiotics and performed urethral catheterization and disimpaction everyday.
Tissue sampling was done on postoperative day 10. Results: No necrosis occurred in
group B, vascularized models. In group A, nonvascularized models, necrosis of the
grafted nerves was observed in 2 of the 4 rats. As for the specimens of Kluver-Barrera’s
method for selective myelin sheath staining, in group B, all specimens were stained
with Kluver-Barrera’s method for selective myelin sheath staining, whereas in group
A, 2 specimens with successful engraftment were not stained. With type IV collagen
immunostaining, the increase of type IV collagen around the grafted area was not so
severe, compared with that of normal region in vascularized cases. In nonvascularized
cases, the appearance of type IV collagen was prominent. Therefore, in the vascularized
cases, it was made clear that Schwann cells survived in vascularized models and that
ﬁbrotic scar formation was inhibited. Conclusion: Histological comparison between
vascularized and nonvascularized peripheral nerve transfer for complete spinal cord gap
showed signiﬁcant differences in 10 days. A longer follow-up period is necessary for
observation of functional differences.
We have performed vascularized nerve transfer in many cases of peripheral nerve
damage. Applying this method on spinal cord repair, we conducted a preliminary study and
assessed its validity, using rats.
The total number of patients with spinal cord injuries in Japan, including con-
genital spina biﬁda or myelomeningocele and myeloschisis, is currently estimated at
approximately 100000. It is estimated that approximately 5000 persons are newly
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affected every year. Although the regeneration of injured spinal cord and restoration of
function are desires common to patients with spinal cord injuries all over the world, a
fundamental treatment has not yet been established. Recently, fetal spinal cord tissue,
Schwann cells (glial cells of the peripheral nervous system), olfactory ensheathing cells,
and various stem cells, including neural stem cells, bone marrow stem cells, and induced
pluripotent stem cells, have been transplanted into experimental animal models.1 A series
of reports of achieving regeneration and functional restoration of the spinal cord after
transplantation of a variety of these tissues and cells attracted much attention. Proper
spatial arrangement of nerve cells and glial cells is required to regenerate tissues of
the spinal cord; surgical techniques to allow this arrangement have not been developed
yet.
In this study, we established and performed a novel transplant, vascularized peripheral
nerve transfer (autologous transplantation), in rats using “super-microsurgery.” We then
histologically assessed the effect of these transplants on spinal cord injuries. In peripheral
nervetransfer,vascularizednerveshavebeenknowntoproduceanacceleratedelongationof
regeneratedaxonscomparedwithnonvascularizednerves.2 Transplantationofvascularized
nerve ﬂaps using microsurgery has been found to achieve better nerve regeneration, even
in cases of a longer nerve defect and with poor blood ﬂow at the recipient site compared
with free nerve transplants, since the survival rate of Schwann cells is almost 100% in these
vascularized nerve ﬂaps. In this study, we examined the application of this technology and
concept to the central nervous system.
The roles of Schwann cells in peripheral nerve repair are as follows: (1) they create
myelinsheathandhelptheaxonalconduction,(2)theyincreaseandmigratetobeascaffold
forregeneratingnerves,and(3)theyproduceneurotrophicfactors.Inthevascularizedgraft,
survivalrate of Schwanncellsis nearly100%, anda sufﬁcientbloodcirculationcan prevent
the ﬁbrotic scar formation.
Since the 1990s, a variety of inhibitory agents in central nerve regeneration were
discovered. Many studies on attempts to regenerate nerves in central nervous system were
done by inhibiting reactions at each stage of tissue repair cascade. Recently, ﬁbrotic scar
formation is reported to play a primary role in the inhibition of central nerve repair.
Vascularizedperipheralnervetransferwassuggestedtobeaneffectivemethodforinhibition
of ﬁbrotic scar. In 1996, much attention was paid to a report by Cheng et al3 published in
Science Magazine, in which axon growth and functional restoration were observed after
bridging spinal cord gaps with a fascicle of intercostal nerves in rats; this procedure is,
however, complicated and further study is not yet performed. Inspired by the report, we
performed peripheral nerve ﬂap transfer for the spinal cord gap. In accordance with other
studies on central nerve regeneration, tissue sampling was done on postoperative day 10.
This is thought to be the shortest duration after which central nerve regeneration begins.
We observed signiﬁcant effects of the vascularized nerve transfer for spinal cord repair,
although the study is still at a preliminary stage. A longer follow-up period is needed to
observe functional differences.
In the future, we plan to pursue the possibility of the vascularized spinal cord transfer
as an innovative approach to the treatment of spinal cord damage, especially ones caused
by tumors (eg, myelomeningocele) and ruptured spines.
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Figure 1. Peripheral nerve transfer for spinal cord (non-
vascularized). Complete spinal cord transection was made
at the level of Th 13, and then intercostal nerves were bun-
dled and grafted. The grafted area was stabilized with ﬁbrin
glue (Beriplast P) containing ﬁbroblast growth factor.
Figure 2. The intercostal artery (A), vein (V), and
nerve (N) of rats.
METHODS
First, we conducted a study similar to that of Cheng et al.3 Next, we made another group
of the vascularized nerve ﬂap transfer. The purpose of this study was to make histolog-
ical comparison between vascularized and nonvascularized peripheral nerve transfers by
making the “vascularized nerve ﬂap” model. Eight female Sprague-Dawley rats were di-
vided into 2 groups: group A and group B. Group A included “nonvascularized nerve
ﬂap” model, the same model used in the study by Cheng et al. Group B consisted of
“vascularized nerve ﬂap” model. A spinal cord segment was completely removed after
laminectomy under deep anesthesia. A sharp scalpel blade was used to transect spinal
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cords. In group A, complete spinal cord transection was made at the level of Th 13, before
intercostal nerves were bundled and grafted. The grafted area was stabilized with ﬁbrin
glue (Beriplast P) containing ﬁbroblast growth factor (Fig 1). In group B, which com-
prised vascularized models, we harvested island intercostal nerve ﬂaps bilaterally at the
same level (Th 13). The nerve ﬂaps were vascularized by the intercostal artery and vein.
The diameter of the artery was approximately 0.2 mm (Fig 2). The 2 island ﬂaps were
folded and bridged to the spinal cord gap. The ﬂaps were ﬁxed with 11–0 nylon sutures.
From its appearance, we named this ﬂap “vascularized cable graft” (Fig 3). Postopera-
tively, intravenous antibiotics were administered every day, and daily urethral catheteriza-
tion and disimpaction were also performed. Tissue sampling was done on postoperative
day 10.
Figure 3. Vascularized nerve ﬂap for complete spinal cord gaps. The 2
island ﬂaps were folded and bridged to the spinal cord gap. The ﬂaps were
ﬁxed with 11–0 nylon sutures.
Figure 4. In the HE staining of group B, sagittal
view of the spinal cord showed that the vascular-
ized nerve ﬂap was grafted successfully (original
magniﬁcation; ×4).
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Figure 5. Kluver-Barrera’s method for selective
myelin sheath staining. In vascularized cases, all
showed positively stained image, and in nonvascular-
ized cases, specimens from the 2 successful engraft-
ment cases showed negatively stained image. Photomi-
crograph of sections of 1-μm thickness that were cut
from the segments and stained. Four specimens of
group A were KB positive, but 2 specimens of group
B were KB negative (original magniﬁcation; ×20).
Figure 6. Entire areas including grafted nerves and
the coaptation sites were carefully harvested and pre-
pared for longitudinal sectioning. At the distal coap-
tation sites (blue arrow), neuroﬁlament ingrowth from
the cord into the graft was observed and compared
between the 2 groups. This immunostaining for an-
tineuroﬁlament antibody showed slight axonal sprout-
ing, but there was no signiﬁcant difference between the
2 groups (original magniﬁcation; ×4).
RESULT
Macroscopically, in vascularized cases (group B), no necrosis occurred, but in nonvas-
cularized cases (group A), necrosis of grafted nerves was observed in 2 of the 4 rats.
In group B, sagittal view of hematoxylin-eosin (HE) staining of the spinal cord showed
that the vascularized nerve ﬂap was grafted successfully (Fig 4). As for the specimens of
Kluver-Barrera’s method for selectivemyelin sheath staining (KB staining), in vascularized
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cases, all showed positively stained image, and in nonvascularized cases, specimens from
2 successful engraftment cases showed negatively stained image. These specimens of KB
staining were made from nerve segments of grafted nerves. Specimens cut from the seg-
ments were 1 μm thick. Four specimens from group A were KB positive, but 2 specimens
from group B were KB negative (Fig 5). Despite the macroscopic similarities, KB staining
clariﬁed a histological difference between group B and the 2 successful engraftment cases
in group A; regarding Schwann cell engraftment, group B was successful and group A was
a failure. In group B, Schwann cells survived much longer than in group A. Immunos-
taining of antineuroﬁlament antibody showed slight axonal sprouting, but there was no
signiﬁcant difference between the 2 groups. Entire areas including grafted nerves and the
coaptation sites were carefully harvested and prepared for longitudinal sectioning. At the
distal coaptation sites (blue arrow) neuroﬁlament ingrowth from the cord into the graft was
observed and compared between the 2 groups (Fig 6). A longer follow-up period is con-
sidered to be necessary for the observation of any histological difference. In glial ﬁbrillary
acidic protein immunostaining, glial scar formation occurred around the grafted area in
both groups (Fig 7). To evaluate ﬁbrotic scar formation in the coaptation sites, 2 mm of
nervesegmentswereharvestedfromthedistalcoaptationsitesandsectionedlongitudinally.
TypeIVcollagenimmunostainingconﬁrmedthatinvascularizedcases,theincreaseoftype
IV collagen around the grafted area was not so signiﬁcant compared with that in normal
area. In 2 specimens of nonvascularized cases, the appearance of type IV collagen was
prominent; the increase of type IV collagen was inhibited only in the vascularized cases.
Four specimens of the vascularized cases were not stained sufﬁciently by this method (Fig
8). Therefore, in the vascularized cases, it was made clear that Schwann cells survived well
in the grafted nerves and ﬁbrotic scar formation between the spinal cord and the grafted
nerves was inhibited. Following Cheng et al’s procedure, in group A, we used ﬁbrin glue
to ﬁx the grafts, but it produced ﬁbrin clots and was surrounded by ﬁbrotic scar. The HE
staining image suggests that ﬁbrin glue might be inhibiting axonal sprouting (Fig 9). A
setback of this spinal cord injury model stems from complete segmental removal of the
cord. Spinal vessels were occluded by severe thrombosis, and histologically, the distal side
of the transected spinal cord showed necrosis and degeneration (Fig 10).
Figure 7. In glial ﬁbrillary acidic protein im-
munostaining, glial scar formation occurred
around the grafted area in both groups (origi-
nal magniﬁcation; ×2).
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Figure 8. To evaluate ﬁbrotic scar formation in
the coaptation sites, nerve segments of 2 mm
were harvested from the distal coaptation sites
and sectioned longitudinally. In the 2 specimens
ofnonvascularizedcases,theappearanceoftype
IV collagen was prominent. On the contrary,
the 4 specimens of the vascularized cases did
not stain well by this immunostaining (original
magniﬁcation; ×10).
Figure 9. Following Cheng et al’s procedure, in group
A, we used ﬁbrin glue to ﬁx the grafts, but it produced
ﬁbrin clots and was surrounded by ﬁbrotic scar. From
this image, ﬁbrin clots might inhibit axonal sprouting
(original magniﬁcation; ×4).
DISCUSSION
For nearly 100 years, it has been considered true that central nerve does not regenerate.
Recently,especiallysince1990s,avarietyofinhibitoryagentsincentralnerveregeneration
have been identiﬁed. And the relationship between ﬁbrotic scar inhibition and central nerve
regeneration has been focused on for many years. More than 50 years ago, it was already
reportedthattheinhibitionofglialscarbydrugsmakescentralnerveregenerationpossible.4
Teng et al5 of the Tokyo Metropolitan Institute for Neuroscience reported that infusion of
dipyridyl, iron chelator, just after nerve tract transection promoted central nervous axonal
sprouting beyond the lesion by inhibiting ﬁbrotic scar formation. Kawano et al6 also used
olfactory ensheathing cells to inhibit the ﬁbrotic scar formation. They transected the spinal
cord with a surgical knife (did not remove it but only made an incision in it) to induce
spinalcordinjury,immediatelyafterwhichtheytransplanted150000olfactoryensheathing
cells into the lesion site. Ten days later, the site was immunostained and examined. They
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reported that ﬁbrotic scar formation was prevented, and transected dopaminergic axons
were regenerated beyond the site of the lesion.4 The inhibition of ﬁbrotic scar might be a
breakthrough in central nerve regeneration.
Figure 10. A drawback of this spinal cord injury model. Spinal
vessels were occluded by severe thrombosis, and the distal side
of the transected spinal cord showed necrosis and degeneration
(original magniﬁcation; ×2).
Figure 11. Future prospects; vascularized spinal cord transfer. A va-
riety of cell transplantations were reported, but the proper spatial ar-
rangementofnervecellsandglialcellsisrequiredtoregeneratetissues
ofthespinalcord,andthereisanissuethatthetechnologiesforachiev-
ing this have not been developed. This vascularized spinal cord ﬂap
can provide solutions to issues surrounding the regenerative medicine
in terms of the vascularized scaffold.
Finally, as future prospects, we plan to design a vascularized spinal cord ﬂap.
A variety of cell transplantations were reported, but the proper spatial arrangement
of nerve cells and glial cells is required to regenerate tissues of the spinal cord, and
there is an issue that the technologies for achieving this have not been developed. The
vascularized spinal cord ﬂap can provide solutions to issues surrounding the regenerative
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medicine in terms of the vascularized scaffold (Fig 11). We examined the vascularity of
rats’ spinal cords with micro computed tomographic system (Fig 12). In the near future, a
hybrid method in which vascularized spinal cord ﬂap transfer is performed with a variety
of cell transplantations is predicted to come into practice. This procedure cannot be done
successfullywithischemicperiod.Wehavealreadydevelopedaspinalcordtransplantmodel
without ischemic period. Anastomosis between the donor’s femoral artery and recipient’s
femoral artery allowed the establishment of retrograde blood ﬂow in the tissue transplant,
preserving the blood ﬂow in the transplanted tissues even when the aorta was clamped.
Therefore, anastomosis of the aorta and vena cava could be performed separately while
conﬁrming that no ischemia was present (Fig 13).
Figure 12. The vascularity of rats’ spinal cords exam-
ined by micro computed tomographic system.
Figure 13. Our ingenuity was employed to eliminate
ischemia. Anastomosis between the donor’s femoral
artery and recipient’s femoral artery allowed the estab-
lishment of retrograde blood ﬂow in the tissue trans-
plant, preserving the blood ﬂow in the transplanted
tissues even when the aorta was clamped. Therefore,
anastomosis of the aorta and vena cava could be per-
formed separately while conﬁrming that no ischemia
was present.
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In this study, we assessed the effect of the vascularized peripheral nerve transfer for
complete spinal cord gap. Histological comparison between vascularized and nonvascular-
ized peripheral nerve transfers for complete spinal cord gap revealed signiﬁcant differences
in10days.Alongerfollow-upperiodisnecessaryforobservationoffunctionaldifferences.
Finally, by modifying this experimental protocol, we will explore the further possibility of
microsurgical spinal cord regeneration.
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